A multi-tiered event to choose the most innovative advancements in diabetes research and care. Tickets for the Semi-Finals can be purchased here.
T1D Exchange and M2D2, a joint venture of the University of Massachusetts Lowell and Worcester campuses that incubates medical device start-ups, have announced the first annual Diabetes Innovation Challenge (2016).
The collaborative objective of T1D Exchange and M2D2 is for the open competition to identify and accelerate transformational advancements in diabetes research and care.
The Diabetes Innovation Challenge will provide up to two awards up to $150,0000 in cash or in-kind services provided by T1 D Exchange, M2D2, and Challenge sponsors, including JDRF, the leading global organization funding type 1 diabetes research program sponsors.
What: Don't miss this valuable opportunity to meet with and preview the selected pool of finalists, who will be showcasing their pre-clinical or translational innovations the evening before the T1D Exchange Annual Meeting, where winning applicants will be announced.
When & Where
T1D Exchange & M2D2
T1D Exchange is recognized leader in global medical and research community.
Despite many advances in the treatment of type 1 diabetes, most patients struggle to meet recommended HbA1c goals, insulin replacement is still the only effective treatment and living with the condition remains a tremendous quality-of-life and financial burden.
T1D Exchange was born out of the need to build a dynamic, multi-purpose, real-world patient data platform that provides researchers seamless access to aggregated clinical, biological, patient-reported outcomes and electronic health record data, all while fostering collaboration among patients, physicians, researchers and industry. The goal is to speed the research process and direct novel treatments and clinical care that will meet unmet needs in type 1 diabetes (T1D). T1D Exchange has completed several intervention studies and has helped successfully accelerate a new formulation of glucagon into a potentially game-changing approach to the treatment of severe hypoglycemia.
T1D Exchange is partnering with M2D2, a joint venture of the University of Massachusetts Lowell and Worcester campuses that incubates medical device start-ups. Together, these organizations have ocreated an open competition to identify and accelerate transformational advancements in diabetes research and care.